Peter Diamandis launches NeoGenesis Capital, a fund betting on superintelligence x synthetic biology
PeterDiamandis · x · 2026-10-14
Peter Diamandis announced NeoGenesis Capital, a new fund focused on the intersection of superintelligence and synthetic biology. He believes some of the most extraordinary breakthroughs of the coming decade will happen at this intersection, with more details to come on the Moonshots podcast.
More from Venture
- Build an AI language-learning game, get 1000 active users first: Oo's challenge — letandrewcook · 2026-10-14
- Dev says open source lets his Sora-style video business turn a profit where OpenAI can't — ctjlewis · 2026-10-14
- Sentry CEO: headless agent signups went to zero after months, so we killed the experiment — zeeg · 2026-10-14
- Crawler health-checks 62K paid APIs and MCP servers: ~1 in 10 is down — BudgetBon · 2026-10-14
- Overjoy's AI-native sales services exit stealth with $1.3M ARR and 2x headcount — julianweisser · 2026-10-14
- The ARR era is over: AI collapses SaaS multiples from 114x to 4x — akumar · 2026-10-14